sb 203580 has been researched along with trichostatin a in 7 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (trichostatin a) | Trials (trichostatin a) | Recent Studies (post-2010) (trichostatin a) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 3,365 | 7 | 1,382 |
Protein | Taxonomy | sb 203580 (IC50) | trichostatin a (IC50) |
---|---|---|---|
Chain A, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN) | Aquifex aeolicus | 0.4 | |
Chain B, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN) | Aquifex aeolicus | 0.4 | |
Chain A, Histone deacetylase 7a | Homo sapiens (human) | 0.3 | |
Chain A, Histone deacetylase 7a | Homo sapiens (human) | 0.3 | |
Histone deacetylase 8 | Schistosoma mansoni | 3.62 | |
Histone deacetylase | Rattus norvegicus (Norway rat) | 0.1854 | |
Histone deacetylase 1 | Mus musculus (house mouse) | 0.0047 | |
Histone deacetylase 3 | Homo sapiens (human) | 0.3388 | |
5-hydroxytryptamine receptor 3A | Cavia porcellus (domestic guinea pig) | 7.69 | |
Histone deacetylase 3 | Mus musculus (house mouse) | 0.0014 | |
Plasma kallikrein | Homo sapiens (human) | 0.034 | |
Integrin beta-3 | Homo sapiens (human) | 0.0263 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.02 | |
Integrin alpha-IIb | Homo sapiens (human) | 0.0263 | |
Coagulation factor VII | Homo sapiens (human) | 0.034 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.005 | |
Vitamin D3 receptor | Homo sapiens (human) | 0.087 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.028 | |
Tissue factor | Homo sapiens (human) | 0.032 | |
Adenosine receptor A1 | Bos taurus (cattle) | 0.19 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.005 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.1 | |
Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 0.1 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.8532 | |
Histone deacetylase 2 | Mus musculus (house mouse) | 0.0014 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.2343 | |
Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.5944 | |
Histone deacetylase 1 | Rattus norvegicus (Norway rat) | 0.1854 | |
Adenosine receptor A1 | Sus scrofa (pig) | 0.2 | |
Histone deacetylase | Rattus norvegicus (Norway rat) | 0.1854 | |
Histone deacetylase 4 | Mus musculus (house mouse) | 0.0014 | |
Polyamine deacetylase HDAC10 | Mus musculus (house mouse) | 0.0014 | |
Histone deacetylase 3 | Rattus norvegicus (Norway rat) | 0.1854 | |
Histone deacetylase-like amidohydrolase | Alcaligenaceae bacterium FB188 | 1.2 | |
Histone deacetylase 7 | Mus musculus (house mouse) | 0.0014 | |
Histone deacetylase 8 | Mus musculus (house mouse) | 0.0207 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.5052 | |
Histone deacetylase 11 | Mus musculus (house mouse) | 0.0014 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.3475 | |
HD2 type histone deacetylase HDA106 | Zea mays | 0.006 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.3266 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.5027 | |
Histone deacetylase 9 | Mus musculus (house mouse) | 0.0014 | |
Histone deacetylase 7 | Rattus norvegicus (Norway rat) | 0.1854 | |
Histone deacetylase 6 | Rattus norvegicus (Norway rat) | 0.1854 | |
Histone deacetylase 4 | Rattus norvegicus (Norway rat) | 0.1854 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.4994 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.2559 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.5627 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.5332 | |
Histone deacetylase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0006 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.0138 | |
Histone deacetylase 6 | Mus musculus (house mouse) | 0.0387 | |
Histone deacetylase 5 | Mus musculus (house mouse) | 0.0107 | |
Histone deacetylase | Zea mays | 0.0004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Erdlenbruch, B; Kanbach, K; Monkemeyer, S; Pekrun, A; Reinhardt, D; Rönndahl, G; Witt, O | 1 |
Adcock, I; Barnes, PJ; Chung, KF; Erdmann, E; Giembycz, M; Ito, K; Jazrawi, E; Koch, A; Lim, S | 1 |
Abad, M; Baniahmad, A; Goeman, F; Palmero, I; Schmidt, O; Serrano, M; Thormeyer, D | 1 |
Baliga, BS; Hunter, R; Johnson, J; McElveen, R; Pace, BS; Qian, XH | 1 |
Cheng, G; Padbury, JF; Tseng, YT; Zhang, LX; Zhao, TC | 1 |
Graham, K; Lanza-Jacoby, S; Yan, G | 1 |
7 other study(ies) available for sb 203580 and trichostatin a
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.
Topics: Amides; Azacitidine; Benzamides; Butyrates; Enzyme Inhibitors; Fetal Hemoglobin; Gene Expression Regulation; Gene Expression Regulation, Leukemic; Globins; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hydroxyurea; Imidazoles; K562 Cells; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Phenylbutyrates; Pyridines; Vorinostat | 2003 |
Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages.
Topics: Acetyltransferases; Adult; Chromatin; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Female; Flavonoids; Granulocyte-Macrophage Colony-Stimulating Factor; Histone Acetyltransferases; Humans; Hydroxamic Acids; I-kappa B Proteins; Imidazoles; Lipopolysaccharides; Macrophages, Alveolar; Male; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Transport; Pyridines | 2004 |
Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.
Topics: Animals; Cell Cycle; Cell Cycle Proteins; Cell Line; Chickens; DNA-Binding Proteins; Enzyme Inhibitors; Fibroblasts; Flavonoids; Gene Deletion; Gene Silencing; Genes, Tumor Suppressor; Humans; Hydroxamic Acids; Imidazoles; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Mice; NIH 3T3 Cells; Nuclear Proteins; Plasmids; Protein Structure, Tertiary; Proteins; Pyridines; ras Proteins; Retroviridae; Signal Transduction; Thymidine; Transcription, Genetic; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2005 |
Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid.
Topics: Anemia, Sickle Cell; Animals; Butyrates; Enzyme Inhibitors; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Gene Silencing; Globins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Imidazoles; K562 Cells; Mice; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Pyridines; Quinolines; RNA, Messenger; Signal Transduction | 2005 |
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Imidazoles; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Inbred ICR; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Ventricular Function, Left | 2007 |
Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Cyclin D1; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Imidazoles; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines | 2013 |